Medical Clinic I, Biomedical Research Laboratory, Goethe-University, Frankfurt, Germany.
Department of Ophthalmology, Experimental Ophthalmology, University Medical Center, Gutenberg University, Mainz, Germany.
Mol Carcinog. 2018 Dec;57(12):1723-1734. doi: 10.1002/mc.22892. Epub 2018 Sep 5.
MutLα, a heterodimer consisting of MLH1 and PMS2, is a key player of DNA mismatch repair (MMR), yet little is known about its regulation. In this study, we used mass spectrometry to identify phosphorylated residues within MLH1 and PMS2. The most frequently detected phosphorylated amino acid was serine 477 of MLH1. Pharmacological treatment indicates that Casein kinase II (CK2) could be responsible for the phosphorylation of MLH1 at serine 477 in vivo. In vitro kinase assay verified MLH1 as a substrate of CK2. Most importantly, using in vitro MMR assay we could demonstrate that p-MLH1 lost MMR activity. Moreover, we found that levels of p-MLH1 varied during the cell cycle. In summary, we identified that phosphorylation of MLH1 by CK2 at amino acid position 477 can switch off MMR activity in vitro. Since CK2 is overexpressed in many tumors and is able to inactivate MMR, the new mechanism here described could have an important impact on tumors overactive in CK2.
MutLα 由 MLH1 和 PMS2 组成的异二聚体,是 DNA 错配修复(MMR)的关键参与者,但其调控机制尚不清楚。在本研究中,我们使用质谱法鉴定了 MLH1 和 PMS2 内磷酸化残基。最常检测到的磷酸化氨基酸是 MLH1 的丝氨酸 477。药物处理表明,酪蛋白激酶 2(CK2)可能负责 MLH1 丝氨酸 477 的体内磷酸化。体外激酶测定验证了 MLH1 是 CK2 的底物。最重要的是,我们使用体外 MMR 测定表明 p-MLH1 失去了 MMR 活性。此外,我们发现 p-MLH1 的水平在细胞周期中发生变化。综上所述,我们发现 CK2 在 MLH1 的氨基酸位置 477 处的磷酸化可以在体外关闭 MMR 活性。由于 CK2 在许多肿瘤中过度表达,并能够使 MMR 失活,因此此处描述的新机制可能对 CK2 过度活跃的肿瘤产生重要影响。